Aoxing Pharmaceutical Company, Inc. (AOXG)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 14.82 Thousand | - | - | - | - | - |
| Selling, General and Administrative Expenses | 14.82 Thousand | - | - | - | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 14.82 Thousand | - | - | - | - | - |
| Operating Income | -14.82 Thousand | - | - | - | - | - |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -167.89 Thousand | - | - | - | - | - |
| Earnings before Tax | -14.82 Thousand | - | - | - | - | - |
| Net Income | -14.82 Thousand | - | - | - | - | - |
| Earnings Per Share Basic | - | - | - | - | - | - |
| Earnings Per Share Diluted | - | - | - | - | - | - |
| Weighted Average Shares Outstanding | 341.2 Million | - | - | - | - | - |
| Weighted Average Shares Outstanding (Diluted) | 341.2 Million | - | - | - | - | - |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -14.82 Thousand | - | - | - | - | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 400.00 | 14.82 Thousand | 1018.00 | 4682.00 | 8725.00 | - |
| Selling, General and Administrative Expenses | 400.00 | - | 1018.00 | 4682.00 | 8725.00 | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 400.00 | 14.82 Thousand | 1018.00 | 4682.00 | 8725.00 | - |
| Operating Income | -400.00 | -14.82 Thousand | -1020.00 | -4680.00 | -8720.00 | - |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -43.81 Thousand | -167.89 Thousand | 39.58 Thousand | -122.08 Thousand | -41.58 Thousand | - |
| Earnings before Tax | -400.00 | -14.82 Thousand | -1018.00 | -4682.00 | -8725.00 | - |
| Net Income | -400.00 | -14.82 Thousand | -1018.00 | -4682.00 | -8725.00 | - |
| Earnings Per Share Basic | - | - | - | - | - | - |
| Earnings Per Share Diluted | - | - | - | - | - | - |
| Weighted Average Shares Outstanding | 341.2 Million | 341.2 Million | 341.2 Million | 341.2 Million | 341.2 Million | - |
| Weighted Average Shares Outstanding (Diluted) | 341.2 Million | 341.2 Million | 341.2 Million | 341.2 Million | 341.2 Million | - |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -400.00 | - | -1020.00 | -4680.00 | -8720.00 | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
9353
6868
6979
CCK
TRIN
ZEOOY